by Brad Dunn | Jan 29, 2021
Sanjay Shukla, MD, the president and CEO of aTyr Pharma, describes how his company works in close conjunction with patient groups — including the Foundation for Sarcoidosis Research — to develop its ATYR1923 therapy for pulmonary sarcoidosis. Pulmonary...
by Brad Dunn | Jan 28, 2021
Elizabeth Berry-Kravis, MD, PhD, co-director of the Molecular Diagnostics Section of the Genetic Laboratory at Rush Medical College in Chicago, offers advice to families struggling with Niemann-Pick Type C (NPC). NPC is a disabling neurogenetic disorder that...
by Brad Dunn | Jan 27, 2021
Elizabeth Berry-Kravis, MD, PhD, co-director of the Molecular Diagnostics Section of the Genetic Laboratory at Rush Medical College in Chicago, talks about advocacy efforts for patients with Niemann-Pick Type C (NPC). NPC is a disabling neurogenetic disorder...
by Brad Dunn | Jan 27, 2021
Adriana Ioachimescu, MD, co-director of the Emory Pituitary Center at the Emory University School of Medicine, gives an overview of acromegaly, including early signs and symptoms that lead to diagnosis. Acromegaly is a hormonal disorder that results from the...
by Brad Dunn | Jan 26, 2021
Ally Roets and her son Sam — who was diagnosed with infantile-onset facioscapulohumeral muscular dystrophy (FSHD) when he was age 6 — discuss the latest research about the disease, as well as technological developments, including exoskeletons, that help...
